Next Article in Journal
Castration Induces Down-Regulation of A-Type K+ Channel in Rat Vas Deferens Smooth Muscle
Next Article in Special Issue
The Role of Extracellular Matrix Expression, ERK1/2 Signaling and Cell Cohesiveness for Cartilage Yield from iPSCs
Previous Article in Journal
Autism Spectrum Disorder-Related Syndromes: Modeling with Drosophila and Rodents
Previous Article in Special Issue
Expression of Osteoblast-Specific Factor 2 (OSF-2, Periostin) Is Associated with Drug Resistance in Ovarian Cancer Cell Lines
Review

Developing Regenerative Treatments for Developmental Defects, Injuries, and Diseases Using Extracellular Matrix Collagen-Targeting Peptides

by 1,2,3, 1,2,3 and 1,2,3,*
1
Surgical Bioengineering Laboratory, Department of Surgery, School of Medicine, University of California Davis, Sacramento, CA 95817, USA
2
Department of Biomedical Engineering, University of California Davis, Davis, CA 95616, USA
3
Institute for Pediatric Regenerative Medicine, Shriners Hospitals for Children, Sacramento, CA 95817, USA
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2019, 20(17), 4072; https://doi.org/10.3390/ijms20174072
Received: 30 July 2019 / Revised: 19 August 2019 / Accepted: 20 August 2019 / Published: 21 August 2019
(This article belongs to the Special Issue Extracellular Matrix in Development and Disease 2.0)
Collagen is the most widespread extracellular matrix (ECM) protein in the body and is important in maintaining the functionality of organs and tissues. Studies have explored interventions using collagen-targeting tissue engineered techniques, using collagen hybridizing or collagen binding peptides, to target or treat dysregulated or injured collagen in developmental defects, injuries, and diseases. Researchers have used collagen-targeting peptides to deliver growth factors, drugs, and genetic materials, to develop bioactive surfaces, and to detect the distribution and status of collagen. All of these approaches have been used for various regenerative medicine applications, including neovascularization, wound healing, and tissue regeneration. In this review, we describe in depth the collagen-targeting approaches for regenerative therapeutics and compare the benefits of using the different molecules for various present and future applications. View Full-Text
Keywords: collagen; extracellular matrix; tissue engineering; regenerative medicine; collagen hybridizing peptide collagen; extracellular matrix; tissue engineering; regenerative medicine; collagen hybridizing peptide
MDPI and ACS Style

Goldbloom-Helzner, L.; Hao, D.; Wang, A. Developing Regenerative Treatments for Developmental Defects, Injuries, and Diseases Using Extracellular Matrix Collagen-Targeting Peptides. Int. J. Mol. Sci. 2019, 20, 4072. https://doi.org/10.3390/ijms20174072

AMA Style

Goldbloom-Helzner L, Hao D, Wang A. Developing Regenerative Treatments for Developmental Defects, Injuries, and Diseases Using Extracellular Matrix Collagen-Targeting Peptides. International Journal of Molecular Sciences. 2019; 20(17):4072. https://doi.org/10.3390/ijms20174072

Chicago/Turabian Style

Goldbloom-Helzner, Leora, Dake Hao, and Aijun Wang. 2019. "Developing Regenerative Treatments for Developmental Defects, Injuries, and Diseases Using Extracellular Matrix Collagen-Targeting Peptides" International Journal of Molecular Sciences 20, no. 17: 4072. https://doi.org/10.3390/ijms20174072

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop